DS
ABBV icon

DRW Securities’s AbbVie ABBV Stock Holding History

DRW Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,200
Closed -$377K – 545
2024
Q2 		$377K Buy
2,200
+1,000
+83% +$166K 0.01% 368
2024
Q1 		$219K Buy
+1,200
New +$207K 0.01% 326

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DRW Securities's ABBV Position: Q1 2026 in Review

DRW Securities opened a new position in AbbVie (ABBV) in Q1 2026: 1,353 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: DRW Securities previously reported a position in ABBV as recently as Q3 2025.

DRW Securities first reported a position in ABBV in Q1 2016 and has held it in 20 quarters since. The position peaked at $8.13M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DRW Securities held 1,353 shares of AbbVie worth $293K as of Q1 2026.
  • AbbVie was a new DRW Securities position in Q1 2026.
  • AbbVie made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #909 holding.
  • DRW Securities first reported a position in AbbVie in Q1 2016 and has held it in 20 quarters since.
  • DRW Securities's AbbVie position peaked at $8.13M in Q1 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.